it sold down close to 60 in 2014 but bounced rather quickly
debt induced buybacks no no no no no
buybacks yes yes yes within fcf and cash build
strategic acquisitions yes yes yes but at a price that makes sense
biopharma and technology have to show future innovation and r&d to keep share prices moving along. IBM csco pfe no growth. nothing wrong with buybacks at good prices but debt shouldrarely be used.
mgt missed recent guidance? what makes u so confident? going into more debt to buyback shares is stupid. the cash hoard should be used eventually to make an acquisition at some point.
ceo is a dope too. only thing these clowns appear to be good at is executing stocks options and selling. why are these dopes getting stock options?